John Libbey Eurotext

Innovations & Thérapeutiques en Oncologie

Innovations & Thérapeutiques en Oncologie

 

The scientific journal of Unicancer, published in partnership with the AERIO and SFjRO, Innovations & Thérapeutiques en Oncologie has two main missions which are :

  • To bring knowledge about the largest number of innovations in oncology, trying as accurately as possible to define their benefits, but also their restrictions and limitations.

  • To echo the everyday impact of both these innovations and also any new methods in clinical practice, new ways of using them and new areas of interest from specific clinical situations.

 

With its eyes set resolutely on the future, the six annual editions of this Journal will quickly find their home with all French speaking oncologists.

 

The Innovations & Thérapeutiques en Oncologie review has an editing committee comprised of successful professionals who are expert in their respective sectors. It can therefore offer you excellent content which will contribute to the development of the future of oncology.

MENU

Volume 8, issue 4, July-August 2022

Éditorial/Editorial

En accès libre Advanced practice registered nurse (APRN) in oncology: an innovation whose missions must be clear
Claude Linassier
Free Access

Humeur/Opinion Column

Article Covidiots and cancer: is there a single stupidity that THEY did not utter?
Jacques Robert, Fabrice Frank, Lonni Besançon, Alexander Samuel, Véronique Saada, Éric Billy, Barbara Seitz-Polski, Jérôme Barrière

Sélection et décryptage/Comments and Analysis

Article Comments and analysis
Patricia de Cremoux, Jacques Robert

Innovations acquises/Acquired Innovations

Article Estrogen receptor alpha (ESR1) gene mutations and hormone therapy resistance in luminal breast cancers: a 2022 update
Patricia De Cremoux, Marc Espié

Article Combining radiotherapy and targeted therapy to treat breast cancer
Arnaud Beddok, Paul Cottu, Alain Fourquet, Youlia Kirova

See full Table of contents >

Archives

See full past issues >

Editorial policy

Here you will find all John Libbey Eurotext (JLE) policies regarding publication in our journals. JLE journals follow the recommendations of the ICMJE (International Committee of Medical Journal Editors). These guidelines are the reference for best practices and ethical standards for the conduct and presentation of research and other information published in medical journals.

 

Version française de notre politique éditoriale